AlphaRx And Gaia BioPharma Report Positive Efficacy Results In A Pre-Clinical Trial Of GAI-122 Injectable Nano-emulsion For Post-operative Delirium

AlphaRx Inc. (OTCBB: ALRX) and Gaia BioPharma Limited reported positive pre-clinical results on GAI-122 injectable nanoemulsion in multiple in vitro and in vivo studies of memory impairment after prolonged anesthesia.

Omega 3 Fatty Acids Appear To Impact AMD Progression

Omega-3 fatty acids found in fatty fish such as tuna and salmon may protect against progression of age-related macular degeneration (AMD), but the benefits appear to depend on the stage of disease and whether certain supplements are taken, report researchers at the Laboratory for Nutrition and Vision Research (LNVR), Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University.

News of the day

Ambulance Service Makes Progress Against Tougher Response Time Targets

Ambulance Trusts across the country have significantly reduced the time taken to reach patients, according to data published today by the NHS Information Centre. 74.3% of the most urgent calls (Category A) were responded to in less than 8 minutes from a call being received.

Your message:
Your name/organization:
Your E-mail:
Enter today\\'s date, 2 digits (spam protection):

AlphaRx And Gaia BioPharma Report Positive Efficacy Results In A Pre-Clinical Trial Of GAI-122 Injectable Nano-emulsion For Post-operative Delirium

Omega 3 Fatty Acids Appear To Impact AMD Progression

Ambulance Service Makes Progress Against Tougher Response Time Targets

Send email